Meet Genmab: International biotechnology
About the company
Genmab is an international biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer.
A perfect match: Utrecht Region matches Genmab’s key site selection drivers
- Access to Utrecht’s strong life sciences and health ecosystem helps strengthen the company’s R&D capabilities
- The availability of a highly educated workforce and the ability to attract and retain key talent is extremely important to the company
Jan van de Winkel, CEO Genmab: "An outstanding biotech hub"
“Utrecht is an excellent location for biotech companies that want to establish their business. The region provides an exceptional innovation ecosystem thanks to the combination of a highly educated workforce, a world-class university, outstanding hospitals and renowned life sciences research institutes. Utrecht is centrally located in the Netherlands and provides an inspirational environment to work, live and relax in.”